mda-mb-436-rfp

MDA-MB-436
 from AcceGen
ABC-TC0655 | 1 vial: Ask for price
Description: The line is pleomorphic and most cells react intensely with anti tubulin antibody as demonstrated by indirect immunofluorescence staining.
MDA-MB-436
 from Addexbio
C0006032 | One Frozen vial: 390.00 EUR
MDA-MB-436
 from Creative Bioarray
CSC-C8864H | One Frozen vial: Ask for price
Description: Breast Carcinoma Cells
MDA-MB-436 Cell Line
 from Elabscience Biotech
CL-0383 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
GFP-Human MDA-MB-435(MDA-MB-435)
 from AcceGen
ABC-RC211D | 1 vial: Ask for price
Description: Human MDA-MB-435 is a cell line isolated from the pleural effusion of a 31 year old female with metastatic, ductal adenocarcinoma of the breast. GFP-expressing MDA-MB-435 (GFP-MDA-MB-435) are selected from MDA-MB-435 cells after infected with lentiviruses expressing GFP with puromycin. The cells are shipped in a frozen vial with more than 5 x 105 cells/vial. Universal Full Growth Medium is recommended for cell culture and these cells have an average minimum population doubling levels > 20 when cultured following the detailed protocol described below.
MDA-MB-157
 from AcceGen
ABC-TC0649 | 1 vial: Ask for price
Description: The cells express the WNT7B oncogene. Desmosomes, microvilli and tonofilaments were observed at boundaries between cells.
MDA-MB-231
 from AcceGen
ABC-TC0651 | 1 vial: Ask for price
Description: Species: human, Caucasian female 51 years old; Tissue: breast; Tumor: adenocarcinoma; Derived from: pleural effusion.
MDA-MB-361
 from AcceGen
ABC-TC0652 | 1 vial: Ask for price
Description: This line differs from others of the series in karyology and in that it was isolated from a brain metastasis.
MDA-MB-415
 from AcceGen
ABC-TC0653 | 1 vial: Ask for price
Description: The cells express the WNT7B oncogene. The patient presenting with the tumor was from Paraguay and, although listed as Caucasian, may have had mixed ancestry as suggested by the presence of G6PD type A phenotype in the cells.
MDA-MB-453
 from AcceGen
ABC-TC0656 | 1 vial: Ask for price
Description: MDA-MB-453 was derived in 1976 by R. Cailleau et al. From an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities.The cells overexpress FGF receptors.
MDA-MB-468
 from AcceGen
ABC-TC0657 | 1 vial: Ask for price
Description: The MDA-MB-468 cell line was isolated in 1977 by R. Cailleau, et al., From a pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast.
MDA-MB-361
 from Addexbio
C0006051 | One Frozen vial: 500.00 EUR
MDA-MB-231
 from Creative Bioarray
CSC-C8210L | One Frozen vial: Ask for price
Description: Breast Carcinoma Cells
MDA-MB-361
 from Creative Bioarray
CSC-C9211W | One Frozen vial: Ask for price
Description: Breast Carcinoma Cells
MDA-MB-468
 from Creative Bioarray
CSC-C9212W | One Frozen vial: Ask for price
Description: Breast Carcinoma Cells
MDA-MB-453
 from Creative Bioarray
CSC-C9488L | One Frozen vial: Ask for price
Description: Breast Carcinoma Cells
MDA-MB-435S
 from AcceGen
ABC-TC0654 | 1 vial: Ask for price
Description: MDA-MB-435S is a spindle shaped strain which evolved from the parent line (435) isolated in 1976 (R. Cailleau et al.) From the pleural effusion of a 31 year old female with metastatic ductal adenocarcinoma of the breast.
MDA-MB-134-VI
 from AcceGen
ABC-TC0648 | 1 vial: Ask for price
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells.
MDA-MB-175-VII
 from AcceGen
ABC-TC0650 | 1 vial: Ask for price
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells.
MDA-MB-231 cells
 from Addexbio
C0006002 | One Frozen vial: 390.00 EUR
MDA-MB-468 cells
 from Addexbio
C0006003 | One Frozen vial: 390.00 EUR
MDA-MB-157 cells
 from Addexbio
C0006020 | One Frozen vial: 390.00 EUR
MDA-MB-175VII cells
 from Addexbio
C0006009 | One Frozen vial: 390.00 EUR
MDA-MB-231 Cell Line
 from Elabscience Biotech
CL-0150 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
MDA-MB-453 Cell Line
 from Elabscience Biotech
CL-0152 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
MDA-MB-468 Cell Line
 from Elabscience Biotech
CL-0290 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
MDA-MB-415 Cell Line
 from Elabscience Biotech
CL-0382 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
MDA-MB-361 Cell Line
 from Elabscience Biotech
CL-0553 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
MDA-MB-175VII Cell Line
 from Elabscience Biotech
CL-0381 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
Human MDA-MB-361 Cell Lysate
 from Innovative research
IHUMDAMB361TL100UG | each: 245.00 EUR
Description: Human MDA-MB-361 Cell Lysate
OCPB00165-100UG - MDA-MB-361 Lysate
 from Aviva Systems Biology
OCPB00165-100UG | 0.1mg: 139.00 EUR
CRISPRa (SAM) MDA-MB-231 Cell Line
 from BPS Bioscience
78521 | 2 vials: 2500.00 EUR
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR-associated protein 9), lacking any endonuclease activity, fused to VP64, a transcriptional activator. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express a construct consisting of P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag (from the MS2 coat protein), which is maintained with Hygromycin resistance. When these cells are transfected with an MS2 aptamer fused to a single guide RNA (sgRNA)targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the promoter in the genomic DNA by the MS2 aptamer and begin transcription, inducing high level expression of the desired protein._x000D_Cells were functionally validated by transfecting the cells with an sgRNA-MS2 targeting PD-1, resulting in high expression of PD-1.
MDA-MB-231 / TetR (Puro) stable cells
 from GenTarget
SC040-TetR | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: Tetracycline repressor expression stable cell line with Puromycin marker in MDA-MB-231 human breast cancer cells.
MDA-MB-453 FFPE Cell Pellet Block
 from Creative Bioarray
BreFFPE-CP001 | 1 Block: Ask for price
Description: Breast
MDA-MB-231 FFPE Cell Pellet Block
 from Creative Bioarray
BreFFPE-CP004 | 1 Block: Ask for price
Description: Breast
MDA-MB-468 FFPE Cell Pellet Block
 from Creative Bioarray
BreFFPE-CP007 | 1 Block: Ask for price
Description: Breast
MDA-MB-453 FFPE Cell Pellet Slides
 from Creative Bioarray
BreFFPE-CP002 | 5 Slides: Ask for price
Description: Breast
MDA-MB-231 FFPE Cell Pellet Slides
 from Creative Bioarray
BreFFPE-CP005 | 5 Slides: Ask for price
Description: Breast
MDA-MB-468 FFPE Cell Pellet Slides
 from Creative Bioarray
BreFFPE-CP008 | 5 Slides: Ask for price
Description: Breast
Human MDA-MB-435S Whole Cell Lysate
 from Innovative research
IHUMDAMB435STLW500UG | each: 327.00 EUR
Description: Human MDA-MB-435S Whole Cell Lysate
MDA-MB-453 FFPE Cell Pellet Scrolls
 from Creative Bioarray
BreFFPE-CP003 | 5 Scrolls: Ask for price
Description: Breast
MDA-MB-231 FFPE Cell Pellet Scrolls
 from Creative Bioarray
BreFFPE-CP006 | 5 Scrolls: Ask for price
Description: Breast
MDA-MB-468 FFPE Cell Pellet Scrolls
 from Creative Bioarray
BreFFPE-CP009 | 5 Scrolls: Ask for price
Description: Breast
Cas9-Expressing MDA-MB-231 cell pool
 from BPS Bioscience
78069 | 2 million cells: 795.00 EUR
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing MDA-MB-231 cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines.
Human MDA-MB-435S Cell Lysate Lyophilized
 from Innovative research
IHUMDAMB435STLLY200UG | each: 89.00 EUR
Description: Human MDA-MB-435S Cell Lysate Lyophilized
Human MDA-MB-361 (Breast Adenocarcinoma) lysate
 from Alpha Diagnostics
HCL-1217 | 100ug: 285.60 EUR
MDA-MB-231 / GFP (Bsd) Stable Cell Line
 from GenTarget
SC040-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: GFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / RFP (Bsd) Stable Cell Line
 from GenTarget
SC057-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: RFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / GFP (Puro) Stable Cell Line
 from GenTarget
SC040-Puro | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance
GFP-Human MDA-MB-231 Breast Cancer Cells
 from AcceGen
ABC-RC207D | 1 vial: Ask for price
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. GFP-MDA-MB-231 cells are selected from puromycin resistant MDA-MB-231 after infected with GFP Expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial.
RFP-Human MDA-MB-231 Breast Cancer Cells
 from AcceGen
ABC-RC208D | 1 vial: Ask for price
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. RFP-MDA-MB-231 cells are selected from Zeocin resistant MDA-MB-231 cells after infected with RFP expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial.
MDA-MB-231 / Luciferase (Bsd) Stable Cell Line
 from GenTarget
SC059-Bsd | 2 x 106 cell/ml x 1ml: 1800.00 EUR
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / Luciferase (Puro) Stable Cell Line
 from GenTarget
SC059-Puro | 2 x 106 cell/ml x 1ml: 1800.00 EUR
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance
OCRA00105-500UG - MDA-MB-435S Whole Cell Lysate
 from Aviva Systems Biology
OCRA00105-500UG | 500ug: 189.00 EUR
MDA-MB-231 / Luciferase-2A-RFP Stable Cell Line
 from GenTarget
SC041 | 2 x 106 cell/ml x 1ml: 2670.00 EUR
Description: Firefly luciferase and GFP co-expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / Luciferase-2A-GFP Stable Cell Line
 from GenTarget
SC044 | 2 x 106 cell/ml x 1ml: 2670.00 EUR
Description: Luciferase (firefry) and GFP co-expression stable cell line in MDA-MB-231 human breast cancer cell line with Puromycin marker.
Human NFkB Luciferase Reporter Cell Line- MDA-MB-231
 from AcceGen
ABC-RC0026 | 1 vial: Ask for price
Description: Human NFkB Luciferase Reporter Cell Line- MDA-MB-231 is derived from Human breast cancer, and stably express firefly luciferase reporter gene under the control of NFkB response element. This cell line is an ideal cellular model for monitoring the activation of NFkB response Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.
MDA-19
 from Abbexa
abx282212-100g | 100 µg: Ask for price
MDA-19
 from Abbexa
abx282212-20g | 20 µg: 175.00 EUR
MDA-19
 from Abbexa
abx282212-50g | 50 µg: 512.50 EUR
MDA 19
 from MedChemExpress
HY-15451 | 5mg: 151.20 EUR
MDA-kb2
 from AcceGen
ABC-TC0647 | 1 vial: Ask for price
Description: Since both glucocorticoid receptor and androgen receptor are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either androgen receptor or glucocorticoid receptor activate the MMTV luciferase.
MDA-5 Antibody
 from NSJ Bioreagents
R35986-100UG | 100 ug: 339.15 EUR
Description: Additional name(s) for this target protein: Melanoma differentiation associated protein-5, IFIH1, interferon induced with helicase C domain 1
Cas9-Expressing MDA-MB-231 Cell Line (High or Low Expression)-78150-H
 from BPS Bioscience
78150-H | 2 vials: 6500.00 EUR
Description: This cell line is a clonal derivative from the Cas9-Expressing MDA-MB-231 Cell Pool (BPS Bioscience, #78069). It was generated by limited limiting dilution of the original pool and isolation of individual clones, which were screened based on Cas9 expression to obtain a low- or high-expressing cell line. The expressed Cas9 protein includes a C-terminal FLAG tag.
Cas9-Expressing MDA-MB-231 Cell Line (High or Low Expression)-78150-L
 from BPS Bioscience
78150-L | 2 vials: 6500.00 EUR
Description: This cell line is a clonal derivative from the Cas9-Expressing MDA-MB-231 Cell Pool (BPS Bioscience, #78069). It was generated by limited limiting dilution of the original pool and isolation of individual clones, which were screened based on Cas9 expression to obtain a low- or high-expressing cell line. The expressed Cas9 protein includes a C-terminal FLAG tag.
MDA Assay Kit
 from Fitzgerald
55R-1512 | 100 assays: 653.00 EUR
Description: Assay Kit for detection of MDA in the research laboratory
Human MDA ELISA
 from Kamiya Biomedical Company
KT-53246 | 96 tests: 1013.00 EUR
MDA Adduct ELISA
 from Kamiya Biomedical Company
KT-956 | 96 tests: 864.00 EUR
MDA-BSA Control
 from Cell Biolabs
STA-333 | 100 µg: 245.00 EUR
(±)-MDA-d3 Hydrochloride
 from Toronto Research Chemicals
M303966 | 25mg: 3000.00 EUR
Malondialdehyde (MDA) (HSA)
 from Abbexa
20-abx281005 | [ 100 ug: Ask for price ] [ 10 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 50 ug: Ask for price ]
Malondialdehyde (MDA) (BSA)
 from Abbexa
abx165775-100g | 100 µg: 1962.50 EUR
Malondialdehyde (MDA) (BSA)
 from Abbexa
abx165775-10g | 10 µg: 512.50 EUR
Malondialdehyde (MDA) (BSA)
 from Abbexa
abx165775-50g | 50 µg: 612.50 EUR
Malondialdehyde (MDA) (OVA)
 from Abbexa
abx165776-100g | 100 µg: 1912.50 EUR
Malondialdehyde (MDA) (OVA)
 from Abbexa
abx165776-10g | 10 µg: 500.00 EUR
Malondialdehyde (MDA) (OVA)
 from Abbexa
abx165776-50g | 50 µg: 600.00 EUR
Malondialdehyde (MDA) (HSA)
 from Abbexa
abx281005-96tests | 96 tests: 1800.00 EUR
Malondialdehyde (MDA) ELISA
 from Kamiya Biomedical Company
KT-21493 | 96 tests: 1032.00 EUR
MDA-7 Rabbit pAb
 from EnoGene
E2251680 | 100ul: 225.00 EUR
Description: Available in various conjugation types.
Malondialdehyde (MDA) Antibody
 from Abbexa
20-abx130475 | [ 100 ug: Ask for price ] [ 10 ug: Ask for price ] [ 1 mg: Ask for price ] [ 200 ug: Ask for price ] [ 50 ug: Ask for price ]
Malondialdehyde (MDA) Antibody
 from Abbexa
abx023266-1ml | 1 ml: 678.00 EUR
Malondialdehyde (MDA) Antibody
 from GenWay Biotech
GWB-5F5329 | 1 ml: Ask for price
Malondialdehyde (MDA) Antibody
 from GenWay Biotech
GWB-15111D | 0.5 mg: Ask for price
Malondialdehyde (MDA) Antibody
 from GenWay Biotech
GWB-67EC7E | 0.5 ml: Ask for price
Malondialdehyde (MDA) Antibody
 from Abbexa
abx130475-100l | 100 µl: 287.50 EUR
Malondialdehyde (MDA) Antibody
 from Abbexa
abx130475-1ml | 1 ml: 850.00 EUR
Malondialdehyde (MDA) Antibody
 from Abbexa
abx130475-200l | 200 µl: 375.00 EUR
<